{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:41:11Z","timestamp":1768070471974,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s11886-017-0868-4","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T01:00:29Z","timestamp":1494810029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Targeted Nuclear Imaging Probes for Cardiac Amyloidosis"],"prefix":"10.1007","volume":"19","author":[{"given":"Paco E.","family":"Bravo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"issue":"1","key":"868_CR1","first-page":"45","volume":"32","author":"RA Kyle","year":"1995","unstructured":"Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32(1):45\u201359.","journal-title":"Semin Hematol"},{"issue":"23","key":"868_CR2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361\u201371.","journal-title":"N Engl J Med"},{"issue":"18","key":"868_CR3","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","volume":"22","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004;22(18):3751\u20137.","journal-title":"J Clin Oncol"},{"issue":"12","key":"868_CR4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","volume":"165","author":"B Ng","year":"2005","unstructured":"Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med. 2005;165(12):1425\u20139.","journal-title":"Arch Intern Med"},{"issue":"4","key":"868_CR5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s002590050406","volume":"26","author":"N Delahaye","year":"1999","unstructured":"Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med. 1999;26(4):416\u201324.","journal-title":"Eur J Nucl Med"},{"issue":"12","key":"868_CR6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jcmg.2016.07.008","volume":"9","author":"V Algalarrondo","year":"2016","unstructured":"Algalarrondo V, Antonini T, Theaudin M, Chemla D, Benmalek A, Lacroix C, et al. Cardiac Dysautonomia predicts long-term survival in hereditary transthyretin amyloidosis after liver transplantation. JACC Cardiovasc Imaging. 2016;9(12):1432\u201341.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"868_CR7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MC Coutinho","year":"2013","unstructured":"Coutinho MC, Cortez-Dias N, Cantinho G, Conceicao I, Oliveira A, Bordalo e Sa A, et al. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging. 2013;6(5):627\u201336.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"868_CR8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46(6):1076\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"868_CR9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","volume":"1","author":"A Castano","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016;1(8):880\u20139.","journal-title":"JAMA Cardiol"},{"issue":"11","key":"868_CR10","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","volume":"15","author":"DF Hutt","year":"2014","unstructured":"Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Eur Heart J Cardiovasc Imaging. 2014;15(11):1289\u201398.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"868_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","volume":"6","author":"S Bokhari","year":"2013","unstructured":"\u2022 Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6(2):195\u2013201. This publication has identified a threshold heart to contralateral lung ratio of > 1.6 as highly specific and sensitive to identify ATTR cardiac amyloidosis.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"24","key":"868_CR12","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"\u2022 Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404\u201312. This is the largest experience to date compiling data from multiple centers and showing the high accuracy of bone imaging in the diagnosis of ATTR cardiac amyloidosis.","journal-title":"Circulation"},{"issue":"2","key":"868_CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1148\/110.2.473","volume":"110","author":"FJ Bonte","year":"1974","unstructured":"Bonte FJ, Parkey RW, Graham KD, Moore J, Stokely EM. A new method for radionuclide imaging of myocardial infarcts. Radiology. 1974;110(2):473\u20134.","journal-title":"Radiology"},{"issue":"6","key":"868_CR14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1172\/JCI108421","volume":"57","author":"LM Buja","year":"1976","unstructured":"Buja LM, Parkey RW, Stokely EM, Bonte FJ, Willerson JT. Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs. J Clin Invest. 1976;57(6):1508\u201322.","journal-title":"J Clin Invest"},{"issue":"7","key":"868_CR15","first-page":"639","volume":"17","author":"MK Dewanjee","year":"1976","unstructured":"Dewanjee MK, Kahn PC. Mechanism of localization of 99mTc-labeled pyrophosphate and tetracycline in infarcted myocardium. J Nucl Med. 1976;17(7):639\u201346.","journal-title":"J Nucl Med"},{"issue":"2","key":"868_CR16","first-page":"284","volume":"38","author":"MB Pepys","year":"1979","unstructured":"Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol. 1979;38(2):284\u201393.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"868_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","volume":"25","author":"MA Stats","year":"2016","unstructured":"Stats MA, Stone JR. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Cardiovasc Pathol. 2016;25(5):413\u20137.","journal-title":"Cardiovasc Pathol"},{"issue":"8","key":"868_CR18","first-page":"1501","volume":"33","author":"T Yamada","year":"1992","unstructured":"Yamada T, Tamaki N, Morishima S, Konishi J, Yoshida A, Matsumori A. Time course of myocardial infarction evaluated by indium-111-antimyosin monoclonal antibody scintigraphy: clinical implications and prognostic value. J Nucl Med. 1992;33(8):1501\u20138.","journal-title":"J Nucl Med"},{"issue":"2\u20133","key":"868_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-5273(02)00555-7","volume":"90","author":"ZJ Margari","year":"2003","unstructured":"Margari ZJ, Anastasiou-Nana MI, Terrovitis J, Toumanidis S, Agapitos EV, Lekakis JP, et al. Indium-111 monoclonal antimyosin cardiac scintigraphy in suspected acute myocarditis: evolution and diagnostic impact. Int J Cardiol. 2003;90(2\u20133):239\u201345.","journal-title":"Int J Cardiol"},{"issue":"2","key":"868_CR20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0002-9149(99)00641-4","volume":"85","author":"JN Nanas","year":"2000","unstructured":"Nanas JN, Margari ZJ, Lekakis JP, Alexopoulos GE, Prassopoulos V, Agapitos EV, et al. Indium-111 monoclonal antimyosin cardiac scintigraphy in men with idiopathic dilated cardiomyopathy. Am J Cardiol. 2000;85(2):214\u201320.","journal-title":"Am J Cardiol"},{"issue":"9","key":"868_CR21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00006231-200209000-00011","volume":"23","author":"RA Valdes Olmos","year":"2002","unstructured":"Valdes Olmos RA, Carrio I, Hoefnagel CA, Estorch M, ten Bokkel Huinink WW, Lopez-Pousa J, et al. High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction. Nucl Med Commun. 2002;23(9):871\u20137.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"868_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0038-1625305","volume":"42","author":"M Unlu","year":"2003","unstructured":"Unlu M, Temiz NH, Cengel A. Myocardial indium-111-antimyosin uptake in essential hypertension. Nuklearmedizin. 2003;42(3):99\u2013103.","journal-title":"Nuklearmedizin"},{"issue":"7","key":"868_CR23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00252992","volume":"13","author":"T Nishimura","year":"1987","unstructured":"Nishimura T, Sada M, Sasaki H, Yutani C, Hayashi M, Amemiya H, et al. Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin. Eur J Nucl Med. 1987;13(7):343\u20137.","journal-title":"Eur J Nucl Med"},{"issue":"7","key":"868_CR24","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0002-9149(97)00558-4","volume":"80","author":"J Lekakis","year":"1997","unstructured":"Lekakis J, Dimopoulos M, Nanas J, Prassopoulos V, Agapitos N, Alexopoulos G, et al. Antimyosin scintigraphy for detection of cardiac amyloidosis. Am J Cardiol. 1997;80(7):963\u20135.","journal-title":"Am J Cardiol"},{"key":"868_CR25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/path.1700860218","volume":"86","author":"JR Hobbs","year":"1963","unstructured":"Hobbs JR, Morgan AD. Fluorescence microscopy with Thioflavine-T in the diagnosis of amyloid. J Pathol Bacteriol. 1963;86:437\u201342.","journal-title":"J Pathol Bacteriol"},{"issue":"13","key":"868_CR26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","volume":"69","author":"WE Klunk","year":"2001","unstructured":"Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Mathis CA. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 2001;69(13):1471\u201384.","journal-title":"Life Sci"},{"issue":"7","key":"868_CR27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"M Biancalana","year":"2010","unstructured":"Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta. 2010;1804(7):1405\u201312.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"868_CR28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsb.2005.06.006","volume":"151","author":"R Khurana","year":"2005","unstructured":"Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover RK, et al. Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol. 2005;151(3):229\u201338.","journal-title":"J Struct Biol"},{"issue":"3","key":"868_CR29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306\u201319.","journal-title":"Ann Neurol"},{"issue":"11","key":"868_CR30","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","volume":"57","author":"WP Law","year":"2016","unstructured":"\u2022 Law WP, Wang WY, Moore PT, Mollee PN, Ng AC. Cardiac amyloid imaging with 18F-Florbetaben PET: a pilot study. J Nucl Med. 2016;57(11):1733\u20139. This was the first publication showing the value of 18F-florbetaben to image cardiac amyloidosis.","journal-title":"J Nucl Med"},{"issue":"3","key":"868_CR31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305(3):275\u201383.","journal-title":"JAMA"},{"issue":"9","key":"868_CR32","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"\u2022 Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR Jr, Di Carli MF, et al. Imaging cardiac amyloidosis: a pilot study using (1)(8)F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41(9):1652\u201362. This was the first publication to show the value of 18F-florbetapir to image cardiac amyloidosis.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"868_CR33","doi-asserted-by":"crossref","unstructured":"\u2022 Park MA, Padera RF, Belanger A, Dubey S, Hwang DH, Veeranna V, et al. 18F\u2013Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015;8(8). This was the first publication to demonstrate specific binding of 18F-florbetapir to myocardial AL and ATTR deposits.","DOI":"10.1161\/CIRCIMAGING.114.002954"},{"key":"868_CR34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","volume":"2","author":"DR Osborne","year":"2015","unstructured":"Osborne DR, Acuff SN, Stuckey A, Wall JS. A routine PET\/CT protocol with streamlined calculations for assessing cardiac amyloidosis using (18)F-Florbetapir. Front Cardiovasc Med. 2015;2:23.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"868_CR35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","volume":"54","author":"G Antoni","year":"2013","unstructured":"\u2022 Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsjo L, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med. 2013;54(2):213\u201320. This was the first publication showing the value of 11C-PIB to image cardiac amyloidosis.","journal-title":"J Nucl Med"},{"issue":"1","key":"868_CR36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","volume":"8","author":"SP Lee","year":"2015","unstructured":"\u2022\u2022 Lee SP, Lee ES, Choi H, Im HJ, Koh Y, Lee MH, et al. 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging. 2015;8(1):50\u20139. This was the first publication showing differences in 11C-PIB uptake among patients with and without prior chemotherapy.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"868_CR37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12350-015-0235-z","volume":"23","author":"S Dorbala","year":"2016","unstructured":"Dorbala S, Kijewski MF, Park MA. Quantitative molecular imaging of cardiac amyloidosis: the journey has begun. J Nucl Cardiol. 2016;23(4):751\u20133.","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"868_CR38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00803246","volume":"9","author":"C Bianchi","year":"1984","unstructured":"Bianchi C, Donadio C, Tramonti G, Lorusso P, Bellitto L, Lunghi F. 99mTc-aprotinin: a new tracer for kidney morphology and function. Eur J Nucl Med. 1984;9(6):257\u201360.","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"868_CR39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(96)13235-3","volume":"220","author":"A Matsumoto","year":"1996","unstructured":"Matsumoto A, Enomoto T, Fujiwara Y, Baba H, Matsumoto R. Enhanced aggregation of beta-amyloid-containing peptides by extracellular matrix and their degradation by the 68 kDa serine protease prepared from human brain. Neurosci Lett. 1996;220(3):159\u201362.","journal-title":"Neurosci Lett"},{"issue":"20","key":"868_CR40","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.1523\/JNEUROSCI.18-20-08311.1998","volume":"18","author":"SA Frautschy","year":"1998","unstructured":"Frautschy SA, Horn DL, Sigel JJ, Harris-White ME, Mendoza JJ, Yang F, et al. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J Neurosci. 1998;18(20):8311\u201321.","journal-title":"J Neurosci"},{"issue":"2","key":"868_CR41","first-page":"177","volume":"44","author":"BK Schaadt","year":"2003","unstructured":"Schaadt BK, Hendel HW, Gimsing P, Jonsson V, Pedersen H, Hesse B. 99mTc-aprotinin scintigraphy in amyloidosis. J Nucl Med. 2003;44(2):177\u201383.","journal-title":"J Nucl Med"},{"issue":"6","key":"868_CR42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0609.2007.00963.x","volume":"79","author":"S Han","year":"2007","unstructured":"Han S, Chong V, Murray T, McDonagh T, Hunter J, Poon FW, et al. Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis. Eur J Haematol. 2007;79(6):494\u2013500.","journal-title":"Eur J Haematol"},{"issue":"3","key":"868_CR43","first-page":"261","volume":"3","author":"R Minamimoto","year":"2013","unstructured":"Minamimoto R, Kubota K, Ishii K, Morooka M, Okasaki M, Miyata Y, et al. Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging. Am J Nucl Med Mol Imaging. 2013;3(3):261\u201371.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"868_CR44","first-page":"257","volume":"88","author":"RW Kozak","year":"1996","unstructured":"Kozak RW, Golker CF, Stadler P. Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological\/biopharmaceutical products: an industry perspective. Dev Biol Stand. 1996;88:257\u201364.","journal-title":"Dev Biol Stand"},{"key":"868_CR45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1749-6632.1982.tb22144.x","volume":"389","author":"MB Pepys","year":"1982","unstructured":"Pepys MB, Baltz ML, de Beer FC, Dyck RF, Holford S, Breathnach SM, et al. Biology of serum amyloid P component. Ann N Y Acad Sci. 1982;389:286\u201398.","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"868_CR46","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","volume":"373","author":"DB Richards","year":"2015","unstructured":"Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, et al. Therapeutic clearance of amyloid by antibodies to serum amyloid P component. N Engl J Med. 2015;373(12):1106\u201314.","journal-title":"N Engl J Med"},{"issue":"8600","key":"868_CR47","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(88)92235-0","volume":"1","author":"PN Hawkins","year":"1988","unstructured":"Hawkins PN, Myers MJ, Lavender JP, Pepys MB. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet. 1988;1(8600):1413\u20138.","journal-title":"Lancet"},{"issue":"8","key":"868_CR48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","volume":"323","author":"PN Hawkins","year":"1990","unstructured":"Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med. 1990;323(8):508\u201313.","journal-title":"N Engl J Med"},{"issue":"7","key":"868_CR49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s002590050273","volume":"25","author":"A Rydh","year":"1998","unstructured":"Rydh A, Suhr O, Hietala SO, Ahlstrom KR, Pepys MB, Hawkins PN. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med. 1998;25(7):709\u201313.","journal-title":"Eur J Nucl Med"},{"issue":"10 Pt 2","key":"868_CR50","first-page":"3831S","volume":"9","author":"A Solomon","year":"2003","unstructured":"Solomon A, Weiss DT, Wall JS. Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4. Clin Cancer Res. 2003;9(10 Pt 2):3831S\u20138S.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"868_CR51","first-page":"2016","volume":"47","author":"JS Wall","year":"2006","unstructured":"Wall JS, Kennel SJ, Paulus M, Gregor J, Richey T, Avenell J, et al. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. J Nucl Med. 2006;47(12):2016\u201324.","journal-title":"J Nucl Med"},{"issue":"13","key":"868_CR52","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1182\/blood-2010-03-273797","volume":"116","author":"JS Wall","year":"2010","unstructured":"Wall JS, Kennel SJ, Stuckey AC, Long MJ, Townsend DW, Smith GT, et al. Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood. 2010;116(13):2241\u20134.","journal-title":"Blood"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-017-0868-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T12:52:34Z","timestamp":1569329554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-017-0868-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s11886-017-0868-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"article-number":"59"}}